Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?

J. Zapf; E. R. Froesch; E. Futo; M Peter

doi:10.1172/jci116152

Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?

J. Zapf(University Hospital of Zurich), E. R. Froesch(München Klinik Schwabing), E. Futo(University Hospital of Zurich), M Peter(University Hospital of Zurich)

Journal of Clinical Investigation

December 1, 1992

10.1172/jci116152

Cited by 173

|Nature|1982|597

Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy Adults

|New England Journal of Medicine|1987|560

Insulin-like growth factors I and II in healthy man.

|European Journal of Endocrinology|1989|547

Synthesis and Secretion of Insulin-Like Growth Factor and Its Binding Protein by the Perfused Rat Liver: Dependence on Growth Hormone Status<sup>*</sup>

|Endocrinology|1983|446

ANTIBODY-SUPPRESSIBLE AND NONSUPPRESSIBLE INSULIN-LIKE ACTIVITIES IN HUMAN SERUM AND THEIR PHYSIOLOGIC SIGNIFICANCE. AN INSULIN ASSAY WITH ADIPOSE TISSUE OF INCREASED PRECISION AND SPECIFICITY*

|Journal of Clinical Investigation|1963|419

Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?

Related Papers